HONG KONG, Dec 13 (Reuters) - Global private equity firms Blackstone (BX.N), opens new tab and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi ...

TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

Investment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group (OTCPK:MTLHY) for approximately 510 billion JPY (3.3 ...

Bain Capital is in talks to acquire Mitsubishi Chemical Group’s41880.75%increase; green up pointing triangle pharmaceutical business in a potential multibillion-dollar deal, a person familiar ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s41880.75%increase; green up pointing triangle pharmaceutical business for more than $3 billion, a deal that would allow the Japanese ...

TOKYO, Feb 7 (Reuters) - U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter said, adding to a dealmaking boom in Japan. The US-based private ...

TOKYO/HONG KONG (Reuters) -Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma ...

HONG KONG (Reuters) - Global private equity firms Blackstone (BX) and Bain Capital (BCSF) are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group ...